Background The Charlson Comorbidity Index (CCI) and its modifications are comorbidity-based measures that predict mortality. It was developed for patients without trauma and inconsistently predicted mortality and adverse events in several previous studies of patients with trauma. Purpose We therefore (1) determined whether the three different CCIs were predictors for in-hospital deaths in patients with hip fractures, (2) verified if the CCI mortality prediction had changed with time, (3) evaluated other predictors of in-hospital death in patients with hip fractures, and (4) determined if the CCI has predicted in-hospital adverse events.
Introduction
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improve their results of national healthcare quality reports, and it may help to adjust for bias in mortality studies.
The Charlson Comorbidity Index (CCI), a score that categorizes and assigns weights and severities to 19 different patient comorbidities, was first reported in 1987 to estimate the probability of death within 1 year [5] . The CCI accurately estimates in-hospital, 30-day, 90-day, and 1-year mortality for patients with breast cancer [5] and after elective surgery [4] . The CCI also correlates with disability, readmission, length of stay [6, 12] , and is associated with death after injury [31] . A higher CCI also is associated with a greater risk for adverse events after spine surgery [1, 10, 20] .
Different variants of CCIs are in use. The CCI has been adapted to ICD-9 codes [9, 31] . Using these ICD-9 codes is reportedly accurate when contrasted with more detailed data obtained directly from medical charts [27] . Charlson et al. developed an age-adjusted CCI in 1994, combining age as an additional weighted variable for mortality prediction [4] . More recently, Quan et al. proposed an updated, reweighted CCI that reportedly predicts in-hospital mortality [26] . They used only 12 of 19 comorbidities and reweighted them, based on changes and improvements in medical care since the introduction of the original CCI in 1987 [26] .
The CCIs were evaluated and validated in patients without trauma. Their utility to predict mortality in patients with trauma is controversial. In some studies the CCI has been associated with mortality [3, 16, 24, 31] and adverse events [2] in elderly patients with fractures. In other studies [11, 22] the CCI did not provide substantial improvement in predicting mortality and was no better than an absolute number achieved by simply counting the preexisting conditions. However, some studies [2, 3, 31] included only isolated fractures or did not control for concomitant injuries, whereas others adjusted for the severity of injuries with the Injury Severity Score [22, 24, 32] . Other limiting factors were the use of different CCI variants in the various studies, the fact that no study focused on change with time, and only one study looked at in-hospital death [32] .
The aims of our study were to (1) determine whether the three different CCIs were predictors for in-hospital deaths in patients with hip fractures, (2) verify if the CCI mortality prediction had changed with time, (3) evaluate other predictors of in-hospital death in patients with hip fractures, and (4) evaluate if the CCI has predicted in-hospital adverse events.
Materials and Methods
The National Hospital Discharge Survey (NHDS) is a collection of inpatient records from more than 500 hospitals and was used to evaluate patients' characteristics and trends [8, 21] . It is a nationwide probability sample survey, started in 1965 then adapted in 1988 from general, nonfederal, less than 30-day-stay hospitals [8] . Demographics, such as age, sex, race, diagnosis and procedural ICD-9 coded medical information, and patients' discharge statuses are included. The NHDS database was obtained from the Centers for Disease Control (CDC) and exported into a statistical program for analysis. An estimated 6,137,965 patients with hip fractures were culled from a database of more than 500,000,000 patients for 1990 to 2007.
All adult patients (older than 18 years) who sustained hip fractures (ICD-9 codes 820.0 and 820.1 transcervical, 820.2 and 820.3 pertrochanteric, and 820.8 and 820.9 not otherwise specified hip fractures) were included in the analysis ( Table 1) ; 73% were women and the most common decade of fracture occurrence was in the 80s (42%) with a total average age of 79 years (range, 18-99 years). Most of the fractures were isolated fractures (93%). In-hospital adverse events were present in 38% of the population (Table 1) , no comorbidities were present in 31%, and the most often encountered comorbidity (34%) was hypertension ( Table 2) . We considered age, sex, single hip fractures versus multiple fractures, type of hip fracture, concomitant head, chest, or abdominal trauma, treatment, adverse events, and days of care as potential predictors. We studied numerous factors included among the CCI comorbidities and others (hypertensive disease, atrial fibrillation, hypothyroidism, alcohol abuse, mood disorder, and obesity) not included in the CCI but reported in the literature as risk factors [2, 19, 23, 32] ( Table 2 ).
The ICD-9 adapted CCI, the age-adjusted CCI, and the 2011 updated CCI by Quan et al. [26] were computed (continuous), stratified into groups by CCI scores (0, 1 and 2, 3 and 4, 5 and more [ Table 3 ]; 0-2, 3, 4, 5, 6, 7, and more than 7 [ Table 4 ]; and 0, 1 and 2, 3 and 4, 5 and more [ Table 5 ]; respectively), and listed by sex, age, days of care, adverse events, transfusion, and discharge status.
Continuous variables were reported as means ± SDs. We assumed they were normally distributed based on the large sample size, and, therefore, were compared using the t-test. Categorical data were reported as relative numbers and assessed using the chi-square test. Three common Charlson indices were used (the ICD-9-adapted CCI [9] , the age-adjusted CCI [4] , and the 2011 updated CCI [26] ) to calculate a continuous comorbidity score.
Continuous variables (age, days of care) of the stratified CCI groups then were analyzed with ANOVA and categorical data (sex, adverse events, transfusion, discharge) with the chi-square test. As a next step, a binary logistic regression analysis was performed of the primary binary outcome (the dependent variable, in-hospital death), and the association of the three comorbidity scores was evaluated. We compared 1990 through 1999 with 2000 through 2007. Logistic regression was used to assess the association of the three Charlson scores (continuous) with the primary outcome in isolation, and to account for bivariate analyses' significant independent variables with backward stepwise logistic regression analyses controlling for age (Charlson and Quan-Charlson), sex, concomitant injuries, and distinct comorbidities not included in the Charlson Index. The predictive accuracy of the models was compared using the R-square measure and the area under the receiver operator curve (ROC) ( Table 6 ). The areas under the ROC of the different CCIs were compared with the Hanley-McNeil test. Then two multivariable analyses for the whole cohort predicting mortality (Table 7 ) and adverse events (Table 8) were performed with a stepwise, backward, logistic (2) the p value in the bivariate analysis was 0.001 or less [21] ; and (3) pooling the variables where possible (all adverse events as a single variable).
Results
All three different CCIs predicted in-hospital deaths in patients with hip fractures. Patients without comorbidities had a 1% to 2% death rate. As more comorbidities were present (a higher Charlson score), the rate substantially and steadily increased up to 9% (Tables 3-5) (p \ 0.001).
There was a less obvious, but still notable trend with adverse events, need for blood transfusions and an increasing chance of being discharged to a long-term facility with an increasing CCI score. The CCI mortality prediction had changed with time. The ability of all three comorbidity indices to predict in-hospital death (measured with the R-square, ROC, and the odds ratio [OR] for the index) decreased when data from 2000 to 2007 were compared with data from 1990 to 1999 (Table 6 ). While controlling for other clinically important factors (age, sex, fracture type, concomitant injuries, treatment, and distinct comorbidities not listed in the CCI) the performance of the models improved considerably; the ROC increased from 0.62 up to 0.77.
While accounting for all available variables, the strongest predictors for in-hospital death in our cohort were adverse events during the hospital stay (OR = 5.16), concomitant chest and abdominal trauma (OR = 3.59), head trauma (OR = 2.03), atrial fibrillation (OR = 2.00), sex (male) (OR = 1.55), the age-adjusted CCI score (OR = 1.33), and pertrochanteric fractures (OR = 1.20) ( Table 7 ). The need for a transfusion was not significant in the bivariate analysis. Patients with hypothyroidism and hypertensive diseases were less likely to die in the hospital (OR = 0.46 and OR = 0.52, respectively) (R-square = 0.17, ROC = 0.81).
The age-adjusted CCI score predicted in-hospital adverse events (Table 8 ). Other important predictors for in-hospital adverse events were pertrochanteric fractures, chest or abdominal trauma, atrial fibrillation, multiple fractures, head trauma, and sex (female); however, the accuracy of this model, based on the area under the curve, was poor (ROC = 0.65). Patients with hypothyroidism and hypertensive disease were slightly less susceptible to suffer any adverse events.
Discussion
Many factors influence in-hospital death and adverse events, including but not limited to patients, surgeons, There are certain limitations that should be accounted for in this retrospective database study. First, although we had patient demographics, factors, and Charlson and non-Charlson associated comorbidities, we did not have other details that may have been influencing the rate of in-hospital death and adverse events, such as diagnosis severity, smoking status, medication details, surgeon, or fracture details. However, this limitation did not affect our first purpose, because the CCI does not include the abovementioned details and is validated with ICD-9 codes only. In contrast, the NHDS provided certain advantages. The database allowed us to look at more than 6 million records of patients with hip fractures, taken from more than half a billion records from 1990 to 2007. Quality control for 2006 and 2007 showed an error rate of 0.2% to 0.3% total for ICD-9 coding and keying, and a 0.2% total for demographic coding and keying [7, 13] . Second, we did not have the details to calculate an established trauma severity score, such as the Injury Severity Score, which could improve the accuracy of a combined model including the CCI to predict mortality if they were used together [32] . Third, certain aspects, such as obesity, were underreported in the NHDS. Fourth, we also could study only inhospital mortality, not 30-day, 90-day, or 1-year mortality. However, inpatient death is the most commonly used outcome measure in quality of care studies. A German study revealed no benefit to longer followups to assess the quality of inpatient care [30] . Knowledge of the factors associated with in-hospital death can help identify patients at risk and provide them special care. It also may help to adjust for bias in mortality studies. Fifth, the ICD-9 based database did not allow us to distinguish comorbidities and complications already present at admission rather than diagnosed during the hospitalization. However, as mentioned by other authors [9, 21] , (1) most comorbidities are clearly coded as chronic diseases and the complications as acute issues, (2) most acute complications probably were not present at admission, because they would have been a contradiction for operative treatment, and (3) we did not use the primary diagnosis as a source for comorbidities. The use of the CCI as a mortality predictor in trauma is disputable. With our data, we support the use of the CCI in a distinct trauma patient cohort as a predictor for in-hospital death. The age-adjusted CCI was the most predictive score in our study.
It is sensible that the CCI would become less useful for the 2000 to 2007 time, compared with 1990 to 1999, owing to better treatment and outcomes with various diseases, such as AIDS. Yet, for hip fracture in-hospital mortality, the 2011 updated CCI had a decreased accuracy, compared with the 1994 age-adjusted CCI, which is interesting when considering the reweighting of the values assigned to each comorbidity. All models increased their performance to predict mortality while adding other variables to the CCI, such as sex, concomitant injuries, type of fracture or treatment, and comorbidities not included in the CCI. Further research on such indices also should focus on these and other parameters [32] .
For hip fractures, the strongest predictors of death were adverse events, concomitant chest and abdominal trauma, head trauma, atrial fibrillation, male sex, and then the ageadjusted CCI. Most factors are comprehensible and already known [15, 28, 29] . Higher mortality among male patients had been observed many times. One such study [14] showed male patients with hip fractures who were 4 years younger than the corresponding female patients and still had substantially higher mortality. Another study [25] found the risk of mortality after hip fracture was twofold that of men, compared with women, which is nearly consistent with our 1.6-fold increase.
The CCI predicts inpatient adverse events in patients with hip fractures, but not very well. Other, more important predictors were pertrochanteric fractures, concomitant injuries, atrial fibrillation, and sex (female) [15, 28, 29] .
The Charlson Comorbidity Indices originally were used as mortality predictors and not adverse event predictors. The accuracy of our model in using the Charlson scores as predictors of death after hip fractures was adequate more so when combined with other important factors, and the accuracy of the model for in-hospital adverse events was poor. Although there are previously discussed limitations, this study's extremely large sample size and large time span allowed us to have feasible generalizability for this study.
